CD22 Targeting-moiety for the treatment of B-cell acute lymphoblastic Leukemia (B-ALL).
IJC
Filing date: 11 Mar, 2020
Licenced date: 16 Jul, 2020
EP20382175.6
ICREA selects researchers based solely on their scientific achievements. However, excellent science often leads to the invention of new and amazing technologies and solutions. When that happens, ICREA fully supports the exploitation of these opportunities.
Our ICREA research professors are working in different Universities and Research Centres. On account of this, ownership of any intellectual or industrial property is always shared between ICREA and the host institution. To make negotiations as fast and conclusive as possible, host institutions are entitled to explore and engage in technology transfer activities on behalf of ICREA when opportunities arise. ICREA supports the exploitation efforts and offers advice throughout the process.
Please have a look at our current technologies and contact ICREA to learn more about them.
IJC
Filing date: 11 Mar, 2020
Licenced date: 16 Jul, 2020
EP20382175.6
Center for Genomic Regulation
Filing date: 14 Feb, 2020
Licenced date: 14 Aug, 2020
018196643
ICN2
Filing date: 30 Dec, 2019
PCT/EP2020/088044
CSIC- 53%
Filing date: 11 Dec, 2019
P201931100
Filing date: 14 Oct, 2019
PCT/EP2019/078408
ICFO
Filing date: 30 Sep, 2019
US62/908,079
ICN2
Filing date: 30 Jul, 2019
Licenced date: 30 Jul, 2021
PCT/EP19382655/071560
IREC
Filing date: 18 Jun, 2019
EP19382509
GALGO SL
Filing date: 17 Jun, 2019
EP19382502
Filing date: 18 Apr, 2019
PCT/ES2019/070270